Shiloh
Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/news-pers...icy-options-conducting-gain-function-research
COMMENTARY: Six policy options for conducting gain-of-function research
Filed Under:
Dual-Use Research; Influenza, General;; Pandemic Influenza
Marc Lipsitch, DPhil, David A. Relman MD, and Thomas V. Inglesby MD
| Mar 08, 2016
Dr. Lipsitch is professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard TH Chan School of Public Health, Boston. Dr. Relman is the Thomas C. and Joan M. Merigan Professor, and co-director of the Center for International Security and Cooperation at Stanford University, Stanford, Calif. Dr. Inglesby is associate professor, University of Pittsburgh Schools of Medicine and Public Health, and director, UPMC Center for Health Security, Baltimore.
A meeting at the National Academy of Sciences (NAS) this week presents a tangible opportunity to spell out concrete steps for research that alters pathogens?and we mustn't let it pass by. We offer several approaches for moving forward.
[h=3]Policy at a turning point[/h] The NAS meeting marks a turning point in a year-and-a-half-long policy process to consider the risks, benefits, oversight, and regulation of experiments that are designed to create influenza and other viruses that are simultaneously highly virulent and readily transmissible by respiratory droplets between mammals...
COMMENTARY: Six policy options for conducting gain-of-function research
Filed Under:
Dual-Use Research; Influenza, General;; Pandemic Influenza
Marc Lipsitch, DPhil, David A. Relman MD, and Thomas V. Inglesby MD
| Mar 08, 2016
Dr. Lipsitch is professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard TH Chan School of Public Health, Boston. Dr. Relman is the Thomas C. and Joan M. Merigan Professor, and co-director of the Center for International Security and Cooperation at Stanford University, Stanford, Calif. Dr. Inglesby is associate professor, University of Pittsburgh Schools of Medicine and Public Health, and director, UPMC Center for Health Security, Baltimore.
A meeting at the National Academy of Sciences (NAS) this week presents a tangible opportunity to spell out concrete steps for research that alters pathogens?and we mustn't let it pass by. We offer several approaches for moving forward.
[h=3]Policy at a turning point[/h] The NAS meeting marks a turning point in a year-and-a-half-long policy process to consider the risks, benefits, oversight, and regulation of experiments that are designed to create influenza and other viruses that are simultaneously highly virulent and readily transmissible by respiratory droplets between mammals...